PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for LXXGQ ( Lexagene Holdings Inc ) from 2017 to May 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Lexagene stock (LXXGQ) PE ratio as of May 19 2024 is 0. More Details

Lexagene Holdings Inc (LXXGQ) PE Ratio (TTM) Chart

To

Lexagene Holdings Inc (LXXGQ) PE Ratio (TTM) Historical Data

Total 1204
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Lexagene PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-20 At Loss 2024-01-04 At Loss
2024-03-08 At Loss 2024-01-03 At Loss
2024-03-07 At Loss 2024-01-02 At Loss
2024-03-06 At Loss 2023-12-29 At Loss
2024-03-05 At Loss 2023-12-28 At Loss
2024-03-04 At Loss 2023-12-27 At Loss
2024-03-01 At Loss 2023-12-26 At Loss
2024-02-29 At Loss 2023-12-22 At Loss
2024-02-28 At Loss 2023-12-21 At Loss
2024-02-27 At Loss 2023-12-20 At Loss
2024-02-26 At Loss 2023-12-19 At Loss
2024-02-23 At Loss 2023-12-18 At Loss
2024-02-22 At Loss 2023-12-15 At Loss
2024-02-21 At Loss 2023-12-14 At Loss
2024-02-20 At Loss 2023-12-13 At Loss
2024-02-16 At Loss 2023-12-12 At Loss
2024-02-15 At Loss 2023-12-11 At Loss
2024-02-14 At Loss 2023-12-08 At Loss
2024-02-13 At Loss 2023-12-07 At Loss
2024-02-12 At Loss 2023-12-06 At Loss
2024-02-09 At Loss 2023-12-05 At Loss
2024-02-08 At Loss 2023-12-04 At Loss
2024-02-07 At Loss 2023-12-01 At Loss
2024-02-06 At Loss 2023-11-30 At Loss
2024-02-05 At Loss 2023-11-29 At Loss
2024-02-02 At Loss 2023-11-28 At Loss
2024-02-01 At Loss 2023-11-27 At Loss
2024-01-31 At Loss 2023-11-22 At Loss
2024-01-30 At Loss 2023-11-21 At Loss
2024-01-29 At Loss 2023-11-20 At Loss
2024-01-26 At Loss 2023-11-17 At Loss
2024-01-25 At Loss 2023-11-16 At Loss
2024-01-24 At Loss 2023-11-15 At Loss
2024-01-23 At Loss 2023-11-14 At Loss
2024-01-22 At Loss 2023-11-13 At Loss
2024-01-19 At Loss 2023-11-10 At Loss
2024-01-18 At Loss 2023-11-09 At Loss
2024-01-17 At Loss 2023-11-08 At Loss
2024-01-16 At Loss 2023-11-07 At Loss
2024-01-12 At Loss 2023-11-06 At Loss
2024-01-11 At Loss 2023-11-03 At Loss
2024-01-10 At Loss 2023-11-02 At Loss
2024-01-09 At Loss 2023-11-01 At Loss
2024-01-08 At Loss 2023-10-31 At Loss
2024-01-05 At Loss 2023-10-30 At Loss

Lexagene Holdings Inc (LXXGQ) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.